Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Phenobarbital (substance) |
Is a |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
forgtiftning med barbituratantiepileptikum |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
1 |
Methylphenobarbitone poisoning |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Accidental methylphenobarbitone poisoning |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Intentional methylphenobarbitone poisoning |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
forgiftning med methylphenobarbiton, uvist med hvilken hensigt |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Barbiturate antiepileptic adverse reaction |
Causative agent |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
1 |
Methylphenobarbitone adverse reaction |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
allergi over for barbituratantiepileptikum |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Allergy to mephobarbital |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
overdosis af barbituratantiepileptikum |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
1 |
Methylphenobarbitone overdose |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Accidental methylphenobarbitone overdose |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Intentional methylphenobarbitone overdose (disorder) |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
overdosis af methylphenobarbiton, uvist med hvilken hensigt |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
barbituratantiepilepticum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Primidone (substance) |
Is a |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Accidental phenobarbitone poisoning |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Intentional phenobarbitone poisoning (disorder) |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
forgiftning med phenobarbiton, uvist med hvilken hensigt |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbitone adverse reaction |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Allergy to phenobarbital |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbitone overdose |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Accidental phenobarbitone overdose |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Intentional phenobarbitone overdose |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
overdosis af phenobarbiton, uvist med hvilken hensigt |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenobarbital 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenobarbital 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenobarbital 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenobarbital 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbitalnatrium 200 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbitalnatrium 15 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbitalnatrium 30 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbitalnatrium 60 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Poisoning by phenobarbital |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital 16.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital 16 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbital 20 mg/5 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Oral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Parenteral phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbitalnatrium 65 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
phenobarbitalnatrium 130 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
belladonna-alkaloider + ergotamintartrat + phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Adverse reaction caused by pentobarbitone (disorder) |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Product containing belladonna alkaloid and phenobarbital (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Pentobarbital (substance) |
Is a |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital (substance) |
Is a |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Methylphenobarbital |
Is a |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
[X]Barbiturates causing adverse effects in therapeutic use, not elsewhere classified |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
[X]Deoxybarbiturates causing adverse effects in therapeutic use |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Deoxybarbiturate (substance) |
Is a |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
allergi over for barbituratantiepileptikum |
Causative agent |
False |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
1 |
Pentobarbital sodium |
Is a |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|
Phenobarbital sodium |
Is a |
True |
Barbiturate antiepileptic (substance) |
Inferred relationship |
Some |
|